FR2100694B1 - - Google Patents

Info

Publication number
FR2100694B1
FR2100694B1 FR7119271A FR7119271A FR2100694B1 FR 2100694 B1 FR2100694 B1 FR 2100694B1 FR 7119271 A FR7119271 A FR 7119271A FR 7119271 A FR7119271 A FR 7119271A FR 2100694 B1 FR2100694 B1 FR 2100694B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7119271A
Other languages
French (fr)
Other versions
FR2100694A1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2100694A1 publication Critical patent/FR2100694A1/fr
Application granted granted Critical
Publication of FR2100694B1 publication Critical patent/FR2100694B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7119271A 1970-05-27 1971-05-27 Expired FR2100694B1 (OSRAM)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4105670A 1970-05-27 1970-05-27
US4465470A 1970-06-08 1970-06-08

Publications (2)

Publication Number Publication Date
FR2100694A1 FR2100694A1 (OSRAM) 1972-03-24
FR2100694B1 true FR2100694B1 (OSRAM) 1974-08-02

Family

ID=26717754

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7119271A Expired FR2100694B1 (OSRAM) 1970-05-27 1971-05-27

Country Status (5)

Country Link
BE (1) BE767707A (OSRAM)
DE (1) DE2126035A1 (OSRAM)
FR (1) FR2100694B1 (OSRAM)
GB (1) GB1347284A (OSRAM)
NL (1) NL145762B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3921460A1 (de) * 1989-06-30 1991-01-03 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3921796A1 (de) * 1989-07-03 1991-01-17 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
US5389675A (en) * 1992-03-27 1995-02-14 The United States Of America As Represented By The Department Of Health And Human Services Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
DE4321109C2 (de) * 1993-06-25 1998-01-29 Sanol Arznei Schwarz Gmbh Pharmakologisch aktive Verbindungen mit Nitrosohydrazinpartialstruktur
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions

Also Published As

Publication number Publication date
NL7106797A (OSRAM) 1971-11-30
GB1347284A (en) 1974-02-27
FR2100694A1 (OSRAM) 1972-03-24
BE767707A (fr) 1971-11-26
NL145762B (nl) 1975-05-15
DE2126035A1 (de) 1971-12-09

Similar Documents

Publication Publication Date Title
AR204384A1 (OSRAM)
FR2100694B1 (OSRAM)
ATA96471A (OSRAM)
AU2044470A (OSRAM)
AU1146470A (OSRAM)
AU1473870A (OSRAM)
AU2085370A (OSRAM)
AU1336970A (OSRAM)
AU2017870A (OSRAM)
AU1833270A (OSRAM)
AU1716970A (OSRAM)
AU2130570A (OSRAM)
AU1517670A (OSRAM)
AU1326870A (OSRAM)
AU1591370A (OSRAM)
AU1841070A (OSRAM)
AU1328670A (OSRAM)
AU2144270A (OSRAM)
AU1343870A (OSRAM)
AU1277070A (OSRAM)
AU2131570A (OSRAM)
AU2130770A (OSRAM)
AU1247570A (OSRAM)
AU1581370A (OSRAM)
AU1235770A (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse